Relation between Efficacy of Adalimumab and Pharmacokinetics in Ulcerative colitis.
Not Applicable
Recruiting
- Conditions
- lcerative colitis
- Registration Number
- JPRN-UMIN000013788
- Lead Sponsor
- Department of Medicine, Shiga University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Patients < 15 years of age (2) Pregnant or likely to be pregnant women (3) Patients with malignancy (4) Patients with severe infection (5) Patients who treated or dose escalated with steroid within 2 weeks. (6) Patients who treated with IFX within 8 weeks (7) Patients who treated or dose escalated with Azathioprine and 6-mercaptopurine within 8 weeks. (8) Patients who treated or dose escalated with tacrolimus within 4 weeks (9) Patients who treated with ciclosporin within 2 weeks (10) Patients who treated with cyteapheresis within 2 weeks (11) Patients not approving the study consent (12) Patients judged as inadequate at the discretion of physicians
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method